Interleukins
Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. A DrugBank category of 26 drugs. 4 of them are approved.
- ATC classification
- Also known as
- Interleukin · Interleukin type substances · Interleukin-2 analogues and derivatives · Interleukin-6 analogues and derivatives · Interleukin-7 analogues and derivatives
- Drugs
- Aldesleukin
- ALT-801
- Bempegaldesleukin
- Binetrakin
- Bizaxofusp
- Cintredekin besudotox
- Denileukin diftitox
- Edodekin alfa
- Efineptakin alfa
- Eflepedocokin alfa
- EGEN-001
- Human Interleukin 8
- Human interleukin-2
- Human interleukin-6
- Interleukin-1 alpha, human recombinant
- Interleukin-10
- Interleukin-15, human recombinant
- Interleukin-7
- Leridistim
- Lorukafusp alfa
- Muplestim
- Nogapendekin alfa
- Oprelvekin
- Pegilodecakin
- Teceleukin
What you can answer from here — as of January 31, 2021
Which targets do Interleukins share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account